Skip to content

COAG-1 PT-NC Test Card

by Cardiovascular Diagnostic Services

510(k) K904325

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK904325 Date25 Jan 1991ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GJS
Device Class
Class II
Regulation
21 CFR Part 864.7750
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The COAG-1 PT-NC Test Card is a diagnostic device classified under hematology, designed for measuring prothrombin time (PT) in blood samples. It is intended for use in coagulation testing to assess the extrinsic pathway of blood clotting, providing quantitative results for monitoring anticoagulant therapy or diagnosing bleeding disorders.

This single-use test card is supplied as a ready-to-use reagent strip for manual or automated coagulation analyzers. It is regulated under FDA 510(k) clearance (K904325) and falls under device classification GJS, adhering to 21 CFR Part 864.7750. The card requires no special storage conditions beyond protection from moisture and extreme temperatures, ensuring stability until use.

Other devices from Cardiovascular Diagnostic Services

See all devices from Cardiovascular Diagnostic Services →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the COAG-1 PT-NC Test Card used for?

    The COAG-1 PT-NC Test Card is designed for measuring prothrombin time (PT) in blood samples. PT testing assesses the extrinsic pathway of blood clotting, which is essential for monitoring patients on anticoagulant therapy (e.g., warfarin) or diagnosing bleeding disorders. Quantitative results help clinicians adjust treatment plans or evaluate coagulation function.

  • How is the COAG-1 PT-NC Test Card supplied and used?

    The COAG-1 PT-NC Test Card is supplied as a single-use, ready-to-use reagent strip. It is compatible with both manual and automated coagulation analyzers, allowing for flexible testing workflows in clinical or point-of-care settings. Each card contains pre-loaded reagents, eliminating the need for additional preparation before use.

  • Is the COAG-1 PT-NC Test Card sterile and single-use?

    Yes, the COAG-1 PT-NC Test Card is intended for single-use only. Single-use design ensures patient safety by preventing cross-contamination and maintaining reagent integrity. Sterility is preserved until the card is opened for use, provided it is stored properly (protected from moisture and extreme temperatures).

  • What storage conditions are required for the COAG-1 PT-NC Test Card?

    The COAG-1 PT-NC Test Card does not require specialized storage conditions beyond protection from moisture and extreme temperatures. This ensures stability and reliability until the time of use. Store in a dry environment, away from direct sunlight or heat sources, to maintain reagent efficacy.

  • What regulatory pathway does the COAG-1 PT-NC Test Card follow?

    The COAG-1 PT-NC Test Card is regulated under the FDA’s 510(k) clearance pathway, specifically classified under device code GJS (Hematology) and adhering to 21 CFR Part 864.7750. It was granted clearance in 1991 (K904325) and is considered substantially equivalent to a predicate device, ensuring compliance with U.S. regulatory standards for coagulation testing.